Peter Riederer

14.6k total citations · 1 hit paper
200 papers, 8.8k citations indexed

About

Peter Riederer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Peter Riederer has authored 200 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Neurology, 56 papers in Cellular and Molecular Neuroscience and 33 papers in Physiology. Recurrent topics in Peter Riederer's work include Parkinson's Disease Mechanisms and Treatments (71 papers), Neurological disorders and treatments (38 papers) and Neuroscience and Neuropharmacology Research (23 papers). Peter Riederer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (71 papers), Neurological disorders and treatments (38 papers) and Neuroscience and Neuropharmacology Research (23 papers). Peter Riederer collaborates with scholars based in Germany, Austria and Denmark. Peter Riederer's co-authors include Moussa B. H. Youdim, W Birkmayer, St. Wuketich, K. A. Jellinger, Toshiharu Nagatsu, M. Gerlach, Hirofumi Inagaki, Masayasu Minami, Minoru Harada and Reinhard Schinzel and has published in prestigious journals such as The Lancet, Annals of Neurology and Scientific Reports.

In The Last Decade

Peter Riederer

197 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

1994 695 citations Peter Riederer, Toshiharu Nagatsu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Riederer Germany	47	3.7k	2.8k	1.7k	1.6k	1.4k	200	8.8k
Francesco Fornai Italy	55	3.7k 1.0×	4.3k 1.5×	3.4k 2.0×	1.7k 1.0×	1.3k 1.0×	383	10.9k
Fabio Blandini Italy	50	3.6k 1.0×	3.0k 1.1×	2.0k 1.2×	1.5k 0.9×	1.2k 0.9×	174	7.9k
James P. O’Callaghan United States	59	1.5k 0.4×	3.6k 1.3×	3.0k 1.7×	2.0k 1.2×	2.5k 1.8×	219	11.4k
Eldad Melamed Israel	65	6.0k 1.6×	4.5k 1.6×	3.7k 2.2×	1.5k 0.9×	1.3k 1.0×	228	13.6k
Gabriele Siciliano Italy	52	2.6k 0.7×	2.3k 0.8×	4.6k 2.7×	2.2k 1.4×	927 0.7×	429	10.1k
Yoshihisa Kitamura Japan	53	1.7k 0.4×	3.1k 1.1×	3.9k 2.3×	2.3k 1.4×	1.9k 1.4×	432	10.4k
Marwan N. Sabbagh United States	53	4.4k 1.2×	1.7k 0.6×	2.0k 1.2×	3.9k 2.4×	1.8k 1.3×	200	10.1k
Seppo Kaakkola Finland	40	2.6k 0.7×	1.8k 0.7×	2.3k 1.3×	1.0k 0.6×	496 0.4×	87	6.8k
Alan M. Palmer United States	40	1.7k 0.4×	2.4k 0.9×	2.4k 1.4×	2.1k 1.3×	868 0.6×	98	8.4k
Régis Bordet France	50	2.5k 0.7×	1.8k 0.7×	2.4k 1.4×	1.2k 0.7×	1.5k 1.1×	313	9.1k

Countries citing papers authored by Peter Riederer

Since Specialization

Citations

This map shows the geographic impact of Peter Riederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Riederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Riederer more than expected).

Fields of papers citing papers by Peter Riederer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Riederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Riederer. The network helps show where Peter Riederer may publish in the future.

Co-authorship network of co-authors of Peter Riederer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Riederer. A scholar is included among the top collaborators of Peter Riederer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Riederer. Peter Riederer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knezović, Ana, Sandy Popp, Gabriela Ortega, et al.. (2025). Approaching therapy of Alzheimer’s disease via the antidiabetic drug liraglutide—a study with streptozotocin intracerebroventricularly treated Wistar rats. Journal of Neural Transmission. 132(10). 1587–1608. 1 indexed citations

Sian‐Hülsmann, Jeswinder, et al.. (2024). Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data. Cells. 13(18). 1511–1511. 1 indexed citations

Leupold, D., et al.. (2024). New Aspects Regarding the Fluorescence Spectra of Melanin and Neuromelanin in Pigmented Human Tissue Concerning Hypoxia. International Journal of Molecular Sciences. 25(15). 8457–8457. 1 indexed citations

Nagatsu, Toshiharu, Akira Nakashima, Hirohisa Watanabe, et al.. (2023). The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease. Journal of Neural Transmission. 130(5). 611–625. 36 indexed citations

Phokaewvarangkul, Onanong, Roongroj Bhidayasiri, Pedro Ruiz, et al.. (2023). Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease: clinical and therapeutic considerations. Journal of Neural Transmission. 130(11). 1451–1462. 9 indexed citations

Wüllner, Ullrich, Per Borghammer, Chi‐un Choe, et al.. (2023). The heterogeneity of Parkinson’s disease. Journal of Neural Transmission. 130(6). 827–838. 41 indexed citations

Tönges, Lars, Carsten Buhmann, Stephan Klebe, et al.. (2022). Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice. Journal of Neural Transmission. 129(9). 1201–1217. 32 indexed citations

Homolak, Jan, Ivan Kodvanj, Ana Babić Perhoč, et al.. (2021). Nitrocellulose redox permanganometry: A simple method for reductive capacity assessment. MethodsX. 9. 101611–101611. 7 indexed citations

Riederer, Peter & Volker ter Meulen. (2020). Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses. Journal of Neural Transmission. 127(9). 1217–1228. 17 indexed citations

10.

Birkmayer, W, J. Knoll, Peter Riederer, & Moussa B. H. Youdim. (2015). (-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson�s Disease. PubMed. 19. 170–176. 10 indexed citations

11.

Šalković‐Petrišić, Melita, Ana Knezović, Jelena Osmanović Barilar, et al.. (2015). Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease. Life Sciences. 136. 108–119. 38 indexed citations

12.

Молочников, Л. С., Jose M. Rabey, Ubaldo Bonuccelli, et al.. (2012). A molecular signature in blood identifies early Parkinson’s disease. Molecular Neurodegeneration. 7(1). 26–26. 97 indexed citations

13.

Riederer, Peter, Manfred Gerlach, Thomas Müller, & Heinz Reichmann. (2007). Relating mode of action to clinical practice: Dopaminergic agents in Parkinson's disease. Parkinsonism & Related Disorders. 13(8). 466–479. 46 indexed citations

14.

Inard, Christian, et al.. (2006). Numerical evaluation of earth to air heat exchangers and heat recovery ventilation systems. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

15.

Baumann, Pierre, Christoph Hiemke, S. Ulrich, et al.. (2004). Therapeutic Monitoring of Psychotropic Drugs. Therapeutic Drug Monitoring. 26(2). 167–170. 34 indexed citations

16.

Baumann, Pierre, Christoph Hiemke, S. Ulrich, et al.. (2004). The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry. Pharmacopsychiatry. 37(6). 243–265. 295 indexed citations

17.

Kahle, Philipp J., Manuela Neumann, Laurence Ozmen, et al.. (2001). Selective Insolubility of α-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model. American Journal Of Pathology. 159(6). 2215–2225. 202 indexed citations

18.

Youdim, Moussa B. H. & Peter Riederer. (1997). Understanding Parkinson's Disease. Scientific American. 276(1). 52–59. 111 indexed citations

19.

Yamamoto, Megumi, Hiroki Ozawa, Toshikazu Saito, et al.. (1996). Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type. Neuroreport. 7(18). 2965–2970. 37 indexed citations

20.

Kienzl, E., et al.. (1985). Veränderungen und Modulation der Rezeptoraktivität bei hepatischer Enzephalopathie. Transfusion Medicine and Hemotherapy. 12(1). 32–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact